RecruitingNot ApplicableNCT03222635

Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma

Endoscopic Management of Patients With High Risk T1a and T1b N0M0 Esophageal Adenocarcinoma: a Prospective Multicenter Registry.


Sponsor

Amsterdam UMC

Enrollment

225 participants

Start Date

Jul 25, 2017

Study Type

INTERVENTIONAL

Conditions

Summary

Aim of this prospective multicenter study is to evaluate the safety of an endoscopic follow-up strategy in patients treated with endoscopic resection (ER) for submucosal or high-risk mucosal esophageal adenocarcinoma (T1bN0M0 or HR T1aN0M0 EAC).


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is tracking patients with a specific early-stage esophageal cancer (called submucosal or high-risk mucosal esophageal adenocarcinoma) after they have had a procedure to remove the cancer using an endoscope, to monitor for recurrence and understand long-term outcomes. **You may be eligible if...** - You have been diagnosed with submucosal or high-risk mucosal esophageal cancer found in a tissue sample removed during an endoscopic procedure - Your diagnosis has been confirmed by a specialist gastrointestinal pathologist - You are willing to sign a consent form **You may NOT be eligible if...** - You have previously had this same type of early esophageal cancer - You also have a different type of esophageal cancer (squamous cell) at the same time - Imaging suggests your cancer may have spread to lymph nodes or distant organs - The cancer was not fully removed during your procedure (positive deep margins) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREEndoscopic follow-up

Endoscopic follow-up by means of regular upper endoscopies and endoscopic ultrasounds


Locations(20)

Westmead hospital

Sydney, Australia

CUB Hôpital Erasme

Brussels, Belgium

AZ Maria Middelares Ghent

Ghent, Belgium

UZ Leuven

Leuven, Belgium

AZ Delta Roeselare

Roeselare, Belgium

Universitätsklinikum Augsburg

Augsburg, Germany

EVK Duesseldorf

Düsseldorf, Germany

MRI TUM

Münich, Germany

Barmherzige Brüder Regensburg

Regensburg, Germany

Amsterdam UMC

Amsterdam, Netherlands

Catharina Hospital

Eindhoven, Netherlands

University Medical Center Groningen

Groningen, Netherlands

St. Antonius Hospital

Nieuwegein, Netherlands

Radboudumc

Nijmegen, Netherlands

Erasmus MC - University Medical Center

Rotterdam, Netherlands

Haga Medical Center

The Hague, Netherlands

Isala Clinics

Zwolle, Netherlands

Hirslanden private hospital group

Zurich, Switzerland

University College London Hospital

London, United Kingdom

Nottingham University Hospitals NHS Trust

Nottingham, United Kingdom

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03222635


Related Trials